Progress and Considerations on the Reform of the Pharmaceutical Excipient Joint Review in China

Lv Xufeng, Yuan Lijia, Wang Jia, Wang Xiaoyan, Xu Pengyao, Zhang Ning

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (2) : 123-129.

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (2) : 123-129. DOI: 10.16153/j.1002-7777.2024.02.001
Supervision Administration

Progress and Considerations on the Reform of the Pharmaceutical Excipient Joint Review in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(2): 123-129 https://doi.org/10.16153/j.1002-7777.2024.02.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉